Rajiv Khanna

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 11

Top Venues

Journal for immunotherapy of cancer

Blood advances

Clinical & translational immunology

PLoS pathogens

QIMR Berghofer Medical Research Institute

Panjab University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

QIMR Berghofer Medical Research Institute

Australia

Coordinator, QIMR Centre for Immunotherapy and Vaccine Development :: Immunology

Education History

Panjab University

India

BSC

Panjab University

India

MSC

Post Graduate Institute of Medical Education and Research

India

PHD :: Experimental Medicine

Publications

Jose Paulo Martins, Rochelle C J D'Souza, Niclas Skarne, Lea Lekieffre, Shane Horsefield, Madusha Ranjankumar, Xiang Li, Thuy T Le, Fiona Smith, Corey Smith, Jacqueline Burrows, Bryan W Day, Rajiv Khanna
EphA3 CAR T cells are effective against glioblastoma in preclinical models. Journal for immunotherapy of cancer 12 (8) (2024)
Jose Paulo Martins, Rochelle C J D'Souza, Niclas Skarne, Lea Lekieffre, Shane Horsefield, Madusha Ranjankumar, Xiang Li, Thuy T Le, Fiona Smith, Corey Smith, Jacqueline Burrows, Bryan W Day, Rajiv Khanna
EphA3 CAR T cells are effective against glioblastoma in preclinical models. Journal for immunotherapy of cancer 12 (8) (2024)
Jose Paulo Martins, Rochelle C J D'Souza, Niclas Skarne, Lea Lekieffre, Shane Horsefield, Madusha Ranjankumar, Xiang Li, Thuy T Le, Fiona Smith, Corey Smith, Jacqueline Burrows, Bryan W Day, Rajiv Khanna
EphA3 CAR T cells are effective against glioblastoma in preclinical models. Journal for immunotherapy of cancer 12 (8) (2024)
Vijayendra Dasari, Lisa K McNeil, Kirrilee Beckett, Matthew Solomon, George Ambalathingal, T Le Thuy, Archana Panikkar, Caitlyn Smith, Martin P Steinbuck, Aniela Jakubowski, Lochana M Seenappa, Erica Palmer, Jeff Zhang, Christopher M Haqq, Peter C DeMuth, Rajiv Khanna
Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing mice. Nature communications 14 (1) (2023)
Vijayendra Dasari, Kirrilee Beckett, Shane Horsefield, George Ambalathingal, Rajiv Khanna
A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice. PLoS pathogens 18 (6) (2022)
Corey Smith, Margaret McGrath, Michelle A Neller, Katherine K Matthews, Pauline Crooks, Laetitia Le Texier, Benedict Panizza, Sandro Porceddu, Rajiv Khanna
Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma. NPJ precision oncology 5 (1) (2021)
Debottam Sinha, Sriganesh Srihari, Kirrliee Beckett, Laetitia Le Texier, Matthew Solomon, Archana Panikkar, George R Ambalathingal, Lea Lekieffre, Pauline Crooks, Sweera Rehan, Michelle A Neller, Corey Smith, Rajiv Khanna
'Off-the-shelf' allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies. Journal for immunotherapy of cancer 9 (2) (2021)
George R Ambalathingal, Ross S Francis, Dillon Corvino, Sriganesh Srihari, Blake T Aftab, Corey Smith, Rajiv Khanna
Proteome-wide analysis of T-cell response to BK polyomavirus in healthy virus carriers and kidney transplant recipients reveals a unique transcriptional and functional profile. Clinical & translational immunology 9 (1) (2020)
Shiney Seo, Corey Smith, Christopher Fraser, Rajan Patheja, Shaheen P Shah, Sweera Rehan, Pauline Crooks, Michelle A Neller, Rajiv Khanna
Adoptive T-cell therapy for pediatric cytomegalovirus-associated retinitis. Blood advances 3 (11) (2020)
Kristine Hardy, Corey Smith, Wen Juan Tu, Robert McCuaig, Archana Panikkar, Vijayendra Dasari, Fan Wu, Siok-Keen Tey, Geoffrey R Hill, Rajiv Khanna, Sudha Rao
Epigenetic programming of T cells impacts immune reconstitution in hematopoietic stem cell transplant recipients. Blood advances 2 (6) (2019)
Rajiv Khanna
EBV and memory B cells: an affair with consequences. Blood 126 (25) (2016)

Rajiv Khanna.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Rajiv Khanna